Tumor Biology

, Volume 36, Issue 4, pp 2583–2591 | Cite as

CIZ1 promoted the growth and migration of gallbladder cancer cells

  • Dexiang Zhang
  • Yueqi Wang
  • Yuedi Dai
  • Jiwen Wang
  • Tao Suo
  • Hongtao Pan
  • Han Liu
  • Sheng Shen
  • Houbao Liu
Research Article


Gallbladder cancer (GBC) is one of the most common and aggressive diseases among the gastrointestinal tract malignancies, and the molecular mechanism underlying this disease remains largely unknown. CIZ1 (Cip1 interacting zinc finger protein 1), a binding partner of p21Cip1/Waf1, has been found to be involved in the tumorigenesis recently. However, the expression pattern and biological functions of CIZ1 in the progression of GBC are not fully understood. In this study, it was found that the expression of CIZ1 was significantly elevated in GBC samples compared to their adjacent normal tissues. Moreover, overexpression of CIZ1 promoted the growth and migration of GBC cells, while knocking down the expression of CIZ1 inhibited the growth, migration, and tumorigenesis of GBC cells in vitro and in vivo. Mechanistically, CIZ1 was found to interact with TCF4 (T-cell factor) and activate beta-catenin/TCF signaling. Our study demonstrated that CIZ1 played an oncogenic role in the progression of GBC and CIZ1 might be a promising target for the treatment of GBC.


CIZ1 Gallbladder cancer Cell growth and migration Beta-catenin/TCF 



This work was supported by the National Natural Science Foundation of China (81272728), the Foundation of Shanghai Science and Technology IIJC1416202, and the Foundation 201440338 from Shanghai.

Conflicts of interest



  1. 1.
    Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Saika K, Machii R. Five-year relative survival rate of gallbladder cancer in the USA, Europe and Japan. Jpn J Clin Oncol. 2014;44(7):704.CrossRefPubMedGoogle Scholar
  3. 3.
    Nishibe R, Watanabe W, Ueda T, et al. CIZ1, a p21Cip1/Waf1-interacting protein, functions as a tumor suppressor in vivo. FEBS Lett. 2013;587(10):1529–35.CrossRefPubMedGoogle Scholar
  4. 4.
    Mitsui K, Matsumoto A, Ohtsuka S, Ohtsubo M, Yoshimura A. Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, CIZ1. Biochem Biophys Res Commun. 1999;264(2):457–64.CrossRefPubMedGoogle Scholar
  5. 5.
    Copeland NA, Sercombe HE, Ainscough JF, Coverley D. CIZ1 cooperates with cyclin-A-CDK2 to activate mammalian DNA replication in vitro. J Cell Sci. 2010;123(Pt 7):1108–15.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Coverley D, Marr J, Ainscough J. CIZ1 promotes mammalian DNA replication. J Cell Sci. 2005;118(Pt 1):101–12.CrossRefPubMedGoogle Scholar
  7. 7.
    Yin J, Wang C, Tang X, et al. CIZ1 regulates the proliferation, cycle distribution and colony formation of RKO human colorectal cancer cells. Mol Med Rep. 2014;8(6):1630–4.Google Scholar
  8. 8.
    Judex M, Neumann E, Lechner S, et al. Laser-mediated microdissection facilitates analysis of area-specific gene expression in rheumatoid synovium. Arthritis Rheum. 2003;48(1):97–102.CrossRefPubMedGoogle Scholar
  9. 9.
    Dahmcke CM, Buchmann-Moller S, Jensen NA, Mitchelmore C. Altered splicing in exon 8 of the DNA replication factor CIZ1 affects subnuclear distribution and is associated with Alzheimer’s disease. Mol Cell Neurosci. 2008;38(4):589–94.CrossRefPubMedGoogle Scholar
  10. 10.
    Ma L, Chen R, Wang L, Yang Y, Wan X. No mutations in CIZ1 in twelve adult-onset primary cervical dystonia families. Mov Disord. 2013;28(13):1899–901.CrossRefPubMedGoogle Scholar
  11. 11.
    Xiao J, Uitti RJ, Zhao Y, et al. Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol. 2012;71(4):458–69.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    den Hollander P, Rayala SK, Coverley D, Kumar R. CIZ1, a novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action. Cancer Res. 2006;66(22):11021–9.CrossRefGoogle Scholar
  13. 13.
    Warder DE, Keherly MJ. CIZ1, Cip1 interacting zinc finger protein 1 binds the consensus DNA sequence ARYSR(0–2)YYAC. J Biomed Sci. 2003;10(4):406–17.PubMedGoogle Scholar
  14. 14.
    Rahman FA, Aziz N, Coverley D. Differential detection of alternatively spliced variants of CIZ1 in normal and cancer cells using a custom exon-junction microarray. BMC Cancer. 2010;10:482.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Higgins G, Roper KM, Watson IJ, et al. Variant CIZ1 is a circulating biomarker for early-stage lung cancer. Proc Natl Acad Sci U S A. 2012;109(45):E3128–35.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Ghosh M, Sakhuja P, Singh S, Agarwal AK. p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer. Saudi J Gastroenterol. 2013;19(1):34–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Moon WS, Park HS, Lee H, et al. Co-expression of cox-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancer. Cancer Res Treat. 2005;37(3):171–6.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kimura Y, Furuhata T, Mukaiya M, et al. Frequent beta-catenin alteration in gallbladder carcinomas. J Exp Clin Cancer Res. 2003;22(2):321–8.PubMedGoogle Scholar
  20. 20.
    Rashid A. Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am. 2002;11(4):995–1009.CrossRefPubMedGoogle Scholar
  21. 21.
    Lien WH, Fuchs E. Wnt some lose some: transcriptional governance of stem cells by Wnt/beta-catenin signaling. Genes Dev. 2014;28(14):1517–32.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Dexiang Zhang
    • 1
  • Yueqi Wang
    • 1
  • Yuedi Dai
    • 2
  • Jiwen Wang
    • 1
  • Tao Suo
    • 1
  • Hongtao Pan
    • 1
  • Han Liu
    • 1
  • Sheng Shen
    • 1
  • Houbao Liu
    • 1
  1. 1.General Surgery Department, Zhongshan Hospital, General Surgery InstituteFudan UniversityShanghaiChina
  2. 2.Department of Medical OncologyCancer Hospital of Fudan University, Minhang BranchShanghaiChina

Personalised recommendations